Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha

Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha

Lalit Mohan Nainwal, Pratap Parida, Aparoop Das, Parth Sarathi Bairy

Comments are closed.